DANA ROSARIO: Open Payments
NPI 1871171900 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,377 in 34 payments from 14 companies in 2025. Trend: 2023 $22 · 2024 $1,137 · 2025 $1,377
Food & beverage: $1,377
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $327 |
| Incyte Corporation | 3 | $279 |
| Daiichi Sankyo Inc. | 7 | $201 |
| GlaxoSmithKline, LLC. | 2 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| Genentech USA, Inc. | 3 | $64 |
| TerSera Therapeutics LLC | 2 | $53 |
| Caris MPI, Inc. | 2 | $47 |
| Gilead Sciences, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
Products named: Jakafi, Enhertu, Nubeqa, JEMPERLI, Zoladex, MI CANCER SEEK, Trodelvy, Ocrevus Zunovo.
Industry payments across NJ — which companies pay providers there.
